Published online Nov 21, 2022. doi: 10.3748/wjg.v28.i43.6078
Peer-review started: September 14, 2022
First decision: October 3, 2022
Revised: October 6, 2022
Accepted: November 4, 2022
Article in press: November 4, 2022
Published online: November 21, 2022
Processing time: 62 Days and 21.7 Hours
This editorial provides an update of the recent evidence on the endoscopy-based Kyoto classification of gastritis, clarifying the shortcomings of the Kyoto classification, and providing prospects for future research, with particular focus on the histological subtypes of gastric cancer (GC) and Helicobacter pylori (H. pylori) infection status. The total Kyoto score is designed to express GC risk on a score ranging from 0 to 8, based on the following five endoscopic findings: Atrophy, intestinal metaplasia (IM), enlarged folds (EF), nodularity, and diffuse redness (DR). The total Kyoto score reflects H. pylori status as follows: 0, ≥ 2, and ≥ 4 indicate a normal stomach, H. pylori-infected gastritis, and gastritis at risk for GC, respectively. Regular arrangement of collecting venules (RAC) predicts non-infection; EF, nodularity, and DR predict current infection; map-like redness (MLR) predicts past infection; and atrophy and IM predict current or past in
Core Tip: Endoscopy-based Kyoto classification of gastritis assesses gastric cancer (GC) risk and Helicobacter pylori (H. pylori) infection status. Total Kyoto scores of 0, ≥ 2, and ≥ 4 indicate a normal stomach, H. pylori-infected gastritis, and gastritis at risk for GC, respectively. Atrophy, intestinal metaplasia (IM), and enlarged folds (EF) increase H. pylori-infected GC incidence. Map-like redness is a specific risk factor for H. pylori-eradicated GC, while regular arrangement of collecting venules result in less GC risk. Diffuse-type GC is induced by active inflammation, depicting EF, nodularity, and atrophy. Intestinal-type GC develops through atrophy and IM; however, the GC risk-scoring design still needs to be improved.
